Your Cart ( 1 Item )

• Early Response is Associated With Stable Long-Term Response in Psoriasis Patients Receiving Ixekizumab or Ustekinumab
  February 2022 | Volume 21 | Issue 2 | Original Article | 122 | Copyright © February 2022
  Mathias Augustin MD^a, Gaia Gallo MD^b, Kyoungah See PhD^b, Missy McKean-Matthews MS^c, Russel Burge PhD^b,d, Melinda Gooderham MSc MD^e, Kristian Reich MD^f
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs